These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25448133)

  • 1. Circulating miR-21, miR-146a and Fas ligand respond to postmenopausal estrogen-based hormone replacement therapy--a study with monozygotic twin pairs.
    Kangas R; Pöllänen E; Rippo MR; Lanzarini C; Prattichizzo F; Niskala P; Jylhävä J; Sipilä S; Kaprio J; Procopio AD; Capri M; Franceschi C; Olivieri F; Kovanen V
    Mech Ageing Dev; 2014 Dec; 143-144():1-8. PubMed ID: 25448133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Declining Physical Performance Associates with Serum FasL, miR-21, and miR-146a in Aging Sprinters.
    Kangas R; Törmäkangas T; Heinonen A; Alen M; Suominen H; Kovanen V; Laakkonen EK; Korhonen MT
    Biomed Res Int; 2017; 2017():8468469. PubMed ID: 28127562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy enhances IGF-1 signaling in skeletal muscle by diminishing miR-182 and miR-223 expressions: a study on postmenopausal monozygotic twin pairs.
    Olivieri F; Ahtiainen M; Lazzarini R; Pöllänen E; Capri M; Lorenzi M; Fulgenzi G; Albertini MC; Salvioli S; Alen MJ; Kujala UM; Borghetti G; Babini L; Kaprio J; Sipilä S; Franceschi C; Kovanen V; Procopio AD
    Aging Cell; 2014 Oct; 13(5):850-61. PubMed ID: 25040542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle function in monozygotic female twin pairs discordant for hormone replacement therapy.
    Finni T; Noorkoiv M; Pöllänen E; Ronkainen PH; Alén M; Kaprio J; Kovanen V; Sipilä S
    Muscle Nerve; 2011 Nov; 44(5):769-75. PubMed ID: 22006692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global gene expression profiles in skeletal muscle of monozygotic female twins discordant for hormone replacement therapy.
    Ronkainen PH; Pöllänen E; Alén M; Pitkänen R; Puolakka J; Kujala UM; Kaprio J; Sipilä S; Kovanen V
    Aging Cell; 2010 Dec; 9(6):1098-110. PubMed ID: 20883525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging and serum exomiR content in women-effects of estrogenic hormone replacement therapy.
    Kangas R; Törmäkangas T; Fey V; Pursiheimo J; Miinalainen I; Alen M; Kaprio J; Sipilä S; Säämänen AM; Kovanen V; Laakkonen EK
    Sci Rep; 2017 Feb; 7():42702. PubMed ID: 28195143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age and estrogen-based hormone therapy affect systemic and local IL-6 and IGF-1 pathways in women.
    Ahtiainen M; Pöllänen E; Ronkainen PH; Alen M; Puolakka J; Kaprio J; Sipilä S; Kovanen V
    Age (Dordr); 2012 Oct; 34(5):1249-60. PubMed ID: 21845403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MitomiRs in human inflamm-aging: a hypothesis involving miR-181a, miR-34a and miR-146a.
    Rippo MR; Olivieri F; Monsurrò V; Prattichizzo F; Albertini MC; Procopio AD
    Exp Gerontol; 2014 Aug; 56():154-63. PubMed ID: 24607549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone therapy is associated with better body composition and adipokine/glucose profiles: a study with monozygotic co-twin control design.
    Ahtiainen M; Alen M; Pöllänen E; Pulkkinen S; Ronkainen PH; Kujala UM; Kaprio J; Sipilä S; Kovanen V
    Menopause; 2012 Dec; 19(12):1329-35. PubMed ID: 22914204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmenopausal hormone replacement therapy modifies skeletal muscle composition and function: a study with monozygotic twin pairs.
    Ronkainen PH; Kovanen V; Alén M; Pöllänen E; Palonen EM; Ankarberg-Lindgren C; Hämäläinen E; Turpeinen U; Kujala UM; Puolakka J; Kaprio J; Sipilä S
    J Appl Physiol (1985); 2009 Jul; 107(1):25-33. PubMed ID: 19246654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women.
    Christodoulakos GE; Lambrinoudaki IV; Creatsa MG; Economou EV; Siasou Z; Panoulis CP; Kalligerou I; Papadias C
    Climacteric; 2008 Apr; 11(2):155-65. PubMed ID: 18365858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESR1 and APOE gene polymorphisms, serum lipids, and hormonal replacement therapy.
    Almeida S; Fiegenbaum M; de Andrade FM; Osório-Wender MC; Hutz MH
    Maturitas; 2006 May; 54(2):119-26. PubMed ID: 16242874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OGT and OGA expression in postmenopausal skeletal muscle associates with hormone replacement therapy and muscle cross-sectional area.
    Toivonen MH; Pöllänen E; Ahtiainen M; Suominen H; Taaffe DR; Cheng S; Takala T; Kujala UM; Tammi MI; Sipilä S; Kovanen V
    Exp Gerontol; 2013 Dec; 48(12):1501-4. PubMed ID: 24365779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.
    de Maat MP; Madsen JS; Langdahl B; Bladbjerg EM; Tofteng CL; Abrahamsen B; Rejnmark L; Brixen K; Christensen K; Jespersen J; Kristensen SR
    Thromb Haemost; 2007 Feb; 97(2):234-9. PubMed ID: 17264952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hormone replacement therapy on plasma pro-inflammatory and anti-inflammatory cytokines and some bone turnover markers in postmenopausal women.
    Vural P; Akgul C; Canbaz M
    Pharmacol Res; 2006 Oct; 54(4):298-302. PubMed ID: 16879975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte and Skeletal Muscle Telomere Length and Body Composition in Monozygotic Twin Pairs Discordant for Long-term Hormone Replacement Therapy.
    Sillanpää E; Niskala P; Laakkonen EK; Ponsot E; Alén M; Kaprio J; Kadi F; Kovanen V; Sipilä S
    Twin Res Hum Genet; 2017 Apr; 20(2):119-131. PubMed ID: 28193312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sex and postmenopausal estrogen use on serum phosphorus levels: a cross-sectional study of the National Health and Nutrition Examination Survey (NHANES) 2003-2006.
    Zhang D; Maalouf NM; Adams-Huet B; Moe OW; Sakhaee K
    Am J Kidney Dis; 2014 Feb; 63(2):198-205. PubMed ID: 24051078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study.
    Khosla S; Atkinson EJ; Melton LJ; Riggs BL
    J Clin Endocrinol Metab; 1997 May; 82(5):1522-7. PubMed ID: 9141544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal leg blood flow in healthy women is related to age and hormone replacement therapy status.
    Moreau KL; Donato AJ; Tanaka H; Jones PP; Gates PE; Seals DR
    J Physiol; 2003 Feb; 547(Pt 1):309-16. PubMed ID: 12562958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of current and past hormone replacement therapy on bone mineral density: a study of discordant postmenopausal twins.
    George GH; MacGregor AJ; Spector TD
    Osteoporos Int; 1999; 9(2):158-62. PubMed ID: 10367044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.